E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 9/17/2014 in the Prospect News Preferred Stock Daily.

Gabelli Healthcare & WellnessRx offering cumulative preferreds talked at 5.875%-6%

By Stephanie N. Rotondo

Phoenix, Sept. 17 – The Gabelli Healthcare & WellnessRx Trust plans to sell series B cumulative preferred shares, according to a prospectus filed with the Securities and Exchange Commission on Wednesday.

Price talk is 5.875% to 6%, according to a trader.

BofA Merrill Lynch is the bookrunner. G. Research Inc. is also participating in the deal.

Dividends are payable on the 26th day of March, June, September and December. The preferreds become redeemable September 2019.

The company will apply to list the new preferreds on the New York Stock Exchange.

Proceeds will be used for investments.

Gabelli Healthcare is a Rye, N.Y.-based diversified, closed-end management investment company.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.